Ka Shing Cheung

7.1k total citations · 1 hit paper
139 papers, 3.4k citations indexed

About

Ka Shing Cheung is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Ka Shing Cheung has authored 139 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Epidemiology, 46 papers in Surgery and 45 papers in Hepatology. Recurrent topics in Ka Shing Cheung's work include Liver Disease Diagnosis and Treatment (42 papers), Hepatitis B Virus Studies (39 papers) and Hepatitis C virus research (36 papers). Ka Shing Cheung is often cited by papers focused on Liver Disease Diagnosis and Treatment (42 papers), Hepatitis B Virus Studies (39 papers) and Hepatitis C virus research (36 papers). Ka Shing Cheung collaborates with scholars based in Hong Kong, China and United Kingdom. Ka Shing Cheung's co-authors include Wai K. Leung, Wai‐Kay Seto, Man‐Fung Yuen, Ching‐Lung Lai, Lung‐Yi Mak, Esther W. Chan, James Fung, Lijia Chen, Ian Chi Kei Wong and Angel Wong and has published in prestigious journals such as Gastroenterology, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Ka Shing Cheung

129 papers receiving 3.4k citations

Hit Papers

Long-term proton pump inhibitors and risk of gastric canc... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori : a population-based study
    2017 313 citations Ka Shing Cheung, Esther W. Chan et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ka Shing Cheung Hong Kong 32 1.7k 1.3k 1.0k 706 407 139 3.4k
Sheng‐Shun Yang Taiwan 27 1.9k 1.1× 1.9k 1.4× 662 0.7× 418 0.6× 268 0.7× 149 3.2k
Sombat Treeprasertsuk Thailand 33 2.0k 1.2× 1.3k 1.0× 839 0.8× 270 0.4× 368 0.9× 190 4.1k
Hyung Joon Yim South Korea 33 2.8k 1.7× 3.1k 2.3× 1.1k 1.1× 461 0.7× 305 0.7× 243 4.7k
Kwan Soo Byun South Korea 31 1.9k 1.1× 1.9k 1.5× 680 0.7× 295 0.4× 268 0.7× 200 3.3k
Jae Young Jang South Korea 31 1.6k 1.0× 1.9k 1.5× 1.0k 1.0× 447 0.6× 427 1.0× 173 3.6k
Woo Jin Chung South Korea 26 958 0.6× 895 0.7× 609 0.6× 507 0.7× 382 0.9× 113 2.4k
Wah‐Kheong Chan Malaysia 30 2.8k 1.7× 1.4k 1.1× 768 0.8× 278 0.4× 232 0.6× 112 3.7k
Dong Hyun Sinn South Korea 41 3.3k 2.0× 3.5k 2.6× 1.5k 1.5× 646 0.9× 812 2.0× 272 5.9k
David E. Kaplan United States 37 2.6k 1.6× 3.0k 2.2× 973 1.0× 376 0.5× 497 1.2× 194 4.8k
Athanasios J. Archimandritis Greece 36 1.9k 1.1× 1.3k 0.9× 884 0.9× 344 0.5× 177 0.4× 134 3.3k

Countries citing papers authored by Ka Shing Cheung

Since Specialization
Citations

This map shows the geographic impact of Ka Shing Cheung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ka Shing Cheung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ka Shing Cheung more than expected).

Fields of papers citing papers by Ka Shing Cheung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ka Shing Cheung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ka Shing Cheung. The network helps show where Ka Shing Cheung may publish in the future.

Co-authorship network of co-authors of Ka Shing Cheung

This figure shows the co-authorship network connecting the top 25 collaborators of Ka Shing Cheung. A scholar is included among the top collaborators of Ka Shing Cheung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ka Shing Cheung. Ka Shing Cheung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zhang, Lina, Yunshi Liao, Ruiqi Zhang, et al.. (2024). Baseline Gut Microbiota Was Associated with Long-Term Immune Response at One Year Following Three Doses of BNT162b2. Vaccines. 12(8). 916–916.
4.
5.
6.
Cheung, Ka Shing, Lung‐Yi Mak, Chi‐Ho Lee, et al.. (2024). Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study. Gut. 73(8). 1313–1320. 5 indexed citations
7.
8.
Leung, Wai K., et al.. (2023). Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection. International Journal of Molecular Sciences. 24(14). 11708–11708. 19 indexed citations
9.
Cheung, Ka Shing, et al.. (2022). Clinical trial: intra dermal hepatitis B vaccination with topical imiquimod versus intra muscular hepatitis B vaccination in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 56(2). 301–309. 4 indexed citations
10.
Pathadka, Swathi, Eric Yuk Fai Wan, Joseph E. Blais, et al.. (2022). Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study. BMJ Open. 12(2). e050510–e050510. 8 indexed citations
11.
Cheung, Ka Shing, Cheng-Zhi Peng, Lung‐Yi Mak, et al.. (2022). Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis. Hepatology. 77(5). 1735–1745. 46 indexed citations
12.
Cheung, Ka Shing, et al.. (2022). COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis. Clinical and Molecular Hepatology. 28(4). 890–911. 24 indexed citations
13.
14.
Guo, Chuan‐Guo, Feifei Zhang, Joseph T. Wu, et al.. (2021). Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy. United European Gastroenterology Journal. 9(5). 543–551. 11 indexed citations
15.
Ng, Pauline Yeung, et al.. (2021). Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer. BMJ Open Gastroenterology. 8(1). e000719–e000719. 9 indexed citations
16.
Guo, Chuan‐Guo, Ka Shing Cheung, Feifei Zhang, et al.. (2020). Delay in Retreatment of Helicobacter pylori Infection Increases Risk of Upper Gastrointestinal Bleeding. Clinical Gastroenterology and Hepatology. 19(2). 314–322.e2. 28 indexed citations
17.
Mak, Lung‐Yi, Chi‐Ho Lee, Ka Shing Cheung, et al.. (2019). Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long‐term nucleoside analogue. Liver International. 39(7). 1217–1225. 15 indexed citations
18.
Seto, Wai‐Kay, Thomas S. Y. Chan, Yu‐Yan Hwang, et al.. (2018). Monitoring and Treatment of Patients Undergoing Immunotherapy With Anti-CD20 Who are Exposed to HBV. Clinical Gastroenterology and Hepatology. 17(7). 1410–1412. 10 indexed citations
19.
Mak, Lung‐Yi, Danny Wong, Ka Shing Cheung, et al.. (2017). Review article: hepatitis B core‐related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection. Alimentary Pharmacology & Therapeutics. 47(1). 43–54. 155 indexed citations
20.
Seto, Wai‐Kay, James Fung, Ka Shing Cheung, et al.. (2016). Body‐mass index is associated with fibrosis regression during long‐term nucleoside analogue therapy in chronic hepatitis B. Alimentary Pharmacology & Therapeutics. 44(10). 1071–1079. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheng‐Shun Yang Breakdown of academic impact, for papers by Sombat Treeprasertsuk Breakdown of academic impact, for papers by Hyung Joon Yim Breakdown of academic impact, for papers by Kwan Soo Byun Breakdown of academic impact, for papers by Jae Young Jang Breakdown of academic impact, for papers by Woo Jin Chung Breakdown of academic impact, for papers by Wah‐Kheong Chan Breakdown of academic impact, for papers by Dong Hyun Sinn Breakdown of academic impact, for papers by David E. Kaplan Breakdown of academic impact, for papers by Athanasios J. Archimandritis
Rankless by CCL
2026